Rapid Diagnostic Testing is fastest growing segment fueling the growth of Chemiluminescence Immunoassay Market
 |
| Chemiluminescence Immunoassay Market |
The global Chemiluminescence
Immunoassay Market is estimated to be valued at US$ 7.01 Bn in 2023 and is
expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market Overview:
Chemiluminescence immunoassay is
a biochemical test used for detection and quantitative measurements of
antibodies, antigens, receptors and other biomarkers. It is widely employed in
endocrinology, cardiology, infectious diseases, drugs of abuse testing and
therapeutic drug monitoring due to accuracy and high sensitivity.
Market key trends:
Rapid diagnostic testing (RDT)
has emerged as the fastest growing segment for chemiluminescence immunoassay
market. RDT products provide quick diagnosis of various infectious diseases in
point-of-care settings such as bedsiders, emergency rooms and clinical
laboratories. They help in timely clinical management of patients and prevent
unnecessary hospitalizations. Various manufacturers are focusing on developing
simple, portable and affordable RDT kits for diseases such as HIV, malaria,
dengue, tuberculosis etc. which is fueling the demand for chemiluminescence
immunoassay globally.
Segment Analysis
The chemiluminescence immunoassay
market is dominated by the Disease Testing subsegment. Disease testing accounts
for the largest market share as chemiluminescence immunoassay is widely used
for disease screening and diagnosis. It is the most preferred technique for
disease testing due to its high sensitivity and specificity.
Key Takeaways
The Global
Chemiluminescence Immunoassay Market Size is expected to witness high
growth, exhibiting CAGR of 8.0% over the forecast period, due to increasing
incidence of chronic and infectious diseases. Rise in geriatric population
prone to various diseases and growth in demand for advanced immunoassay
techniques are also fueling the market growth.
Regional analysis
The North American region
dominates the chemiluminescence immunoassay market owing to rising healthcare
expenditure, prevalence of lifestyle diseases, availability of advanced
healthcare facilities and presence of leading market players in the region.
Asia Pacific is expected to witness the highest growth during the forecast
period owing to increasing healthcare expenditures, growing medical tourism
industry and rising awareness regarding disease screening and diagnostics in
developing countries of the region.
Key players
Key players operating in the
chemiluminescence immunoassay market are DiaSorin S.p.A., Abbott Laboratories,
Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers,
Beckman Coulter Inc., F. Hoffmann-La Roche AG, Inova Diagnostics, Inc., Maccura
Biotechnology Co., Ltd., Tosoh Corporation, and Ortho Clinical Diagnostic.
DiaSorin S.p.A. and Abbott Laboratories dominate the global market owing to
their robust product portfolios and strong geographical presence across the
world.
Get More Insights:
https://www.newsstatix.com/chemiluminescence-immunoassay-market-size-share-growth-outlook-2023/
Comments
Post a Comment